Navigation Links
The Law Firm of Levi & Korsinsky Launches an Investigation Into Possible Breaches of Fiduciary Duties and Unjust Enrichment by the Board of Directors of Abbott Laboratories, Inc.
Date:12/2/2011

NEW YORK, Dec. 2, 2011 /PRNewswire/ -- Levi & Korsinsky is investigating potential claims on behalf of long-term shareholders of Abbott Laboratories, Inc. ("Abbott" or the "Company") (NYSE: ABT) concerning improper conduct by the Company regarding the marketing and sale of the anti-seizure medication Depakote.

For more information, click here: http://zlk.9nl.com/abbott-laboratories-abt.

From as early as 1998, Abbott is alleged to have trained sales representatives to promote off-label uses of Depakote and provide illegal kick-backs to physicians.  Consequently, Abbott was investigated by the Department of Justice ("DOJ").  In an October 19, 2011 SEC filing, Abbott disclosed that the Company had reserved $1.5 billion of litigation reserves "related to ongoing settlement discussions" with the DOJ.   The investigation focuses, among other things, on the conduct of Abbott's Board of Directors in affirmatively adopting, implementing, and condoning a business strategy based on deliberate and widespread illegal conduct that has now resulted in substantial potential damages to the Company.

If you own Abbott common stock and wish to obtain additional information about this investigation and your legal rights, please contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://www.zlk.com/abbott-laboratories-abt.html.

Levi & Korsinsky has expertise in prosecuting investor securities litigation and extensive experience in actions involving financial fraud, representing investors throughout the nation, concentrating its practice in securities and shareholder litigation. Attorney advertising. Prior results do no
'/>"/>

SOURCE Levi & Korsinsky, LLP
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Frost & Sullivan: Western European Markets Confirm Undisputed Convenience and Cost Benefit of Custom Procedure Trays
2. Boston Scientific and Johnson & Johnson Announce Settlement of Patent Disputes
3. Tata Interactive Systems Partners With Bersin & Associates for Exclusive Executive Learning Forum - TLF 2009
4. Sigma-Aldrich (Nasdaq: SIAL) Announces Appointment of George Miller as Sr. Vice President, General Counsel & Secretary
5. Robbins & Myers Announces Regular Quarterly Cash Dividend
6. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
7. Frost & Sullivan Lauds Viatronix as European Medical Imaging Emerging Company of the Year
8. Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
9. Robbins & Myers Announces Fourth Quarter and Full Year 2009 Results
10. Dynatronics Appoints Douglas Sampson as Vice President of Production and Research & Development
11. Frost & Sullivan Identifies Focus on Quality Management and Adoption of a Full-service Model as Keys to the Growth of the European CRO Market
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 2013 , Safinamide significantly ... patients as add-on to levodopa Safinamide ... symptoms in fluctuating PD patients as add-on to ... S.p.A. ("Newron"), a research and development company focused ... partner Zambon S.p.A., a pharmaceutical company strongly committed ...
(Date:6/18/2013)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... public offering of common shares (the "Offering"). Pursuant to ... at a price of $85.00 per share, for aggregate ... file a final prospectus supplement to its effective shelf ... similar filing with the securities regulatory authorities in each ...
(Date:6/18/2013)... , June 18, 2013  It has ... of Alliance Seating and Mobility, a subsidiary company ... access timely repair. This appears to be due ... reduction of field service employees.  ... great many of these clients are complex mobility ...
Breaking Medicine Technology:Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Valeant Pharmaceuticals Prices Public Offering Of Common Shares 2Valeant Pharmaceuticals Prices Public Offering Of Common Shares 3Valeant Pharmaceuticals Prices Public Offering Of Common Shares 4
(Date:6/19/2013)... (PRWEB) June 19, 2013 Blueforce ... and sensor machine software, today announced it has ... its Decentralized Fusion Engine technology. The award ... the acquisition of key strategic partnerships. , ... wireless collaboration and machine-to-machine (M2M) software products that ...
(Date:6/19/2013)... A blow to the head; a swift jarring to ... to hours. It’s understandable, but what else may follow ... traumatic brain injury. According to mayoclinic.com , usual ... But many other symptoms may follow, sometimes not for ... include ongoing headaches, dizziness, feeling like you’re in a fog, ...
(Date:6/19/2013)... 19, 2013 Walkingspree, a specialized wellness ... the launch of its new Facebook App. This is ... inspire participants to reach their program fitness goals. Consistent ... Walkingspree clients are given more tools to customize their ... , Corporate clients may choose whether or not they ...
(Date:6/19/2013)... Weight gain and obesity have been ... including heart disease, kidney failure and high blood pressure. ... and unnecessary fat, have many people searching for fast ... diets to not only allow patients to succeed ... aim to reduce the risk for many weight-related health ...
(Date:6/19/2013)... June 19, 2013 The reason for the ... because users can place a 4x8 flood tray inside the ... to work around. In addition, Gorilla Grow Tents are ... are the tallest, thickest and strongest grow tents on the ... grow tent standards. , Gorilla Grow Tents are ...
Breaking Medicine News(10 mins):Health News:Blueforce Awarded Patent for Decentralized Sensor Fusion 2Health News:Concussions Can Lead to Much More Than a Headache, According to MMTR Health Inc. Founder, Terry Moore, Neuromuscular and Cardiovascular Physiologist 2Health News:Walkingspree’s New Facebook Connectivity Boosts Accountability and Engagement 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Fast Weight Loss Programs for Patients Suffering with Health Care Concerns 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Offers New Fast Weight Loss Programs for Patients Suffering with Health Care Concerns 3Health News:Stealth Grow Tent Brand’s Popularity Rises 2
... disused proteins are eliminated by a cellular shredder called ... to dispose with Ubiquitin (Ub) in order to avoid ... in the ubiquitin-proteasome system can be fatal for the ... disorders but also developmental defects are the consequences. The ...
... the first scientific review of a dozen patients who have ... gene therapy technique is safe and may be effective at ... patients, half of whom live on Long Island, are in ... to medicines when they signed on for the experimental therapy. ...
... on June 26, after spending 23 days in the slammer. ... Angeles County Sheriff's Department's Inmate Reception Center. ,The exact ... ,Although her sentence was for 45 days, authorities have said ... good behaviour. ,"There was some confusion as to whether ...
... new details about how proteins used to destroy bacteria ... ,Gunnar K. Gouras, associate professor of neurology and ... York, and colleagues provide new insights into how these ... disease and raise hopes for a vaccine against the ...
... a credible scientific method for testing and measuring ... on XanGo Juice , indicate usage of the ... to high xanthone absorption. ,XanGo, LLC, ... leading scientific exploration of the whole mangosteen fruit ...
... is making all possible arrangements to look good on her yet ... thing that the socialite will do after being released on June ... complained to the press while in jail that she's not permitted ... going dry. ,So, the heiress has booked a facial ...
Cached Medicine News:Health News:Protein Targets for Carcinogenesis 2Health News:Gene Therapy for Parkinsons Disease 2Health News:Researchers Link Bacteria Destroying Proteins to Alzheimer's Treatment 2Health News:Researchers Link Bacteria Destroying Proteins to Alzheimer's Treatment 3Health News:New Technique to Measure Xanthone in Mangosteen 2Health News:New Technique to Measure Xanthone in Mangosteen 3
Blunt Weitlaner Retractor....
Weitlaner Beckmann retractor, sharp prongs, SS....
Baby Weitlaner retractor, blunt, 4"....
Scoville sharp curette, 10, straight, scoop size 4 x 10 mm....
Medicine Products: